Fig. 3
From: Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension
Correlations between IL-32 sera levels and both mPAP and sPAP. a The correlation analysis of IL-32 sera levels and mPAP shows that the IL-32 sera levels of patients with SSc correlate with mPAP measures (r2 = 0.13; p = 0.02). b The correlation analysis of IL-32 sera levels and sPAP shows that the IL-32 sera levels of patients with SSc correlate with sPAP measures (r2 = 0.7; p < 0.0001)